TY - JOUR T1 - Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. JO - Clin Endocrinol (Oxf) PY - 2014/02/17 AU - Pivonello R AU - Petersenn S AU - Newell-Price J AU - Findling JW AU - Gu F AU - Maldonado M AU - Trovato A AU - Hughes G AU - Salgado LR AU - Lacroix A AU - Schopohl J et al ED - DO - DOI: 10.1111/cen.12431 VL - 81 IS - 3 SP - 408 EP - 417 Y2 - 2025/06/26 ER -